Patents & Intellectual Properties From Dr. Muhammed Majeed
Patents & Intellectual Properties
Innovation recognized by the world
| No | Title | Patent No | Brand /Ingredient |
| 01 | Use of piperine to increase bioavailability of nutritional compounds | US 5,536,506 | BioPerine® |
| 02 | Use of piperine as a bioavailability enhancer | US 5,744,161 | BioPerine® |
| 03 | Potassium hydroxycitrate for the suppression of appetite and induction of weight loss | US 5,783,603 | Citrin®K |
| 04 | Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders | US 5,804,596 | ForsLean® |
| 05 | Bioprotectant composition, method of use and extraction process of curcuminoids | US 5,861,415 | Curcumin C3 Complex® |
| 06 | Use of piperine as a bioavailability enhancer | US 5,972,382 | BioPerine® |
| 07 | Process for making high purity piperine for nutritional use | US 6,054,585 | BioPerine® |
| 08 | Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease. | US 6,436,991 | Gugulipid® |
| 09 | Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii | US 6,607,712 | Coleus Oil |
| 10 | Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays | US 6,653,327 | Tetrahydrocurcuminoids |
| 11 | Process of obtaining compositions of stable lutein and lutein derivatives | US 6,689,400 | ZeaLutein® |
| 12 | Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid | US 6,770,782 | Citrin®K |
| 13 | Manufacturing Processes for Se-Methyl-Selenocysteine | US 6,794,537 | Methyselene® |
| 14 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | US 6,849,645 | Cosmoperine®(THP) |
| 15 | Process for preparing water soluble diterpenes and their applications | US 6,960,300 | Forskolin Eye Drops |
| 16 | Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use | US 6,982,273 | Methyselene® |
| 17 | A convenient process of manufacture for Difluoromethylornithine and related compounds | US 6,998,502 | Efflornithine |
| 18 | A convenient process of manufacture for Difluoromethylornithine and related compounds | US 7,345,196 | Efflornithine |
| 19 | Compositions and methods containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | US 7,014,874 | SelenoForce |
| 20 | Bioavailable composition of natural and synthetic HCA | US 7,063,861 | GarCitrin® |
| 21 | Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels | US 7,160,562 | Metformin-Like Compounds |
| 22 | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: Process for their manufacture and Uses | US 7,202,270 | Liposol® |
| 23 | Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails | US 7,217,546 | Policosanol |
| 24 | Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers | US 7,253,324 | Stilbenes |
| 25 | Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance | US 7,300,682 | Cococin™ |
| 26 | New chemical entities with multiple modes of anti-inflammatory action | US 7,371,889 | AKBBA+NSAIDS |
| 27 | New Chemical entities with multiple modes of anti-inflammatory action | US 7,378,442 | AKBBA+NSAIDS |
| 28 | Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives | US 7,514,573 | 3-Aminotetrahydrofurans |
| 29 | Novel non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4 hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis) | US 7,521,580 | Curcuminoid analogs |
| 30 | Composition and methods for the management of hyperproliferative dermatological conditions | US 7,582,314 | Boswellin® |
| 31 | Hydro-alkoxyl citronellal compounds - synthetic routes, compositions and uses thereof | US 7,842,842 | Odorants |
| 32 | Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis | US 8,003,614 | Selenium Dipeptides |
| 33 | Treatment of superficial and cutaneous mycoses with a pure form of 1,7-bis(4-hydroxy-3-methoxyphe nyl)-3,5-heptanedione | US 8,119,696 | Tetrapure® |
| 34 | Dipeptides incorporating selenoamino acids with enhanced bioavailability--synthesis, pharmaceutical and cosmeceutical applications thereof (Preparation of LSM and methods of VEGF enhancement and 5-alpha-reductase inhibition) | US 8,193,156 | LSM-Dipeptide Synthetic route |
| 35 | Protective compositions for dermal papilla cells | US 8,247, 003 | Saberry® + Cococin™ |
| 36 | Preservative system for cosmetic formulations—compositions and methods thereof | US 8,329,095 | SabiLize® |
| 37 | Compositions and its use in treating obesity or inducing weight loss | US 8,329,743 | Anti-obesity composition |
| 38 | Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals | US 8,383,594 | Cosmeceutical Peptide |
| 39 | Inotilone derivatives as coherent biological response modifier (cBMR) | US 8,394,852 | Inotilone derivatives |
| 40 | Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 8,853,407 | Pharmaceutical intermediates |
| 41 | Anti-obesity potential of Calebin A | US 8,933,121 | Calebinoids |
| 42 | Oleanoyl Peptide Composition and Method of Treating Skin Aging | US 8,987,212 | Olepent® |
| 43 | Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 9,029,547 | Pharmaceutical Intermediates |
| 44 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,029,424 | 3-hydroxypterostilbene |
| 45 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,050,284 | 3-hydroxypterostilbene |
| 46 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,056,074 | 3-hydroxypterostilbene |
| 47 | Composition and method for the protection of articular cartilage | US 9,220,703 | Calebin |
| 48 | Anti-obesity potential of Calebin A | US 9,328,330 | Calebin |
| 49 | Synthesis of Calebin A and its biologically active analogs | US 9,365,486 | Calebin |
| 50 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,387,193 | Cyperus |
| 51 | Process for the manufacture of 3'-hydroxy pterostilbene | US 9,458,075 | 3-hydroxypterostilbene |
| 52 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | US 9,498,423 | Saberry® + Cococin™ + Se Peptide |
| 53 | Calebin A for osteoporosis | US 9,539,232 | Calebin |
| 54 | Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans | US 9,579,352 | LactoSpore® |
| 55 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | US 9,596,861 | LactoSporin® |
| 56 | Method for the treatment of hypercholesterolemia | US 9,610,273 | Calebin |
| 57 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | US 9,635,862 | LactoSporin® + Biofilm inhibition |
| 58 | Method for the treatment of hypercholesterolemia | US 9,668,999 | Calebin |
| 59 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | US 9,681,665 | LactoSporin® + Antimicrobial |
| 60 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | US 9,681,666 | LactoSporin® + SabiLize® + Antimicrobial |
| 61 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 9,717,766 | LactoSpore® + Cranberry Fibers for increasing colony count |
| 62 | Calebin A for hepatic steatosis | US 9,737,502 | Calebin |
| 63 | Composition Comprising Scirpusin A and Scirpusin B and Anti-Obesity Potential Thereof | US 9,782,450 | Cyperus |
| 64 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene | US 9,833,422 | Zingiber cassumnar |
| 65 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene | US 9,913,809 | Zingiber cassumnar |
| 66 | Oleanoyl peptide composition and skin hydration | US 10,071,043 | Olepent® |
| 67 | Process and compositions for achieving mammalian energy balance | US 10,085,963 | Forskolin |
| 68 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | US 10,166,261 | LactoSpore® |
| 69 | Composition comprising Scirpusin a and Scirpusin b and anti-obesity potential thereof | US 10,172,903 | Cyperus |
| 70 | Functional nutritional blend for thermo-metabolic performance | US 10,258,073 | Metabolicgard |
| 71 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | US 10,260,112 | LactoSpore® |
| 72 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 10,293,008 | LactoSpore® |
| 73 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | US 10,323,227 | LactoSpore® + Turmeric starch |
| 74 | Process for synthesis of Oroxylin A | US 10,407,401 | Oroxylin |
| 75 | Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | US 10,421,734 | 3-Amino Tetrahydrofurans |
| No | Title | Patent No | Brand /Ingredient |
| 01 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Australia AU2006235807 |
Curcumin C3 Reduct® |
| 02 | Bioavailable composition of natural and synthetic HCA | Australia AU773081 |
GarCitrin® |
| 03 | Compositions and methods for the management of hyperproliferative dermatological conditions | Australia AU2004322710 |
Boswellin® |
| 04 | Compositions containing Allium Sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Australia AU2006321973 |
SelenoForce® |
| 05 | Process for preparing water soluble diterpenes and their applications | Australia AU2004272005 |
Ocufors® |
| 06 | Antiobesity potential of Calebin A | Australia AU2012366253 |
Calebin |
| 07 | Hepatoprotectant activity of garcinol | Australia AU2011352073 |
Garcinol |
| 08 | Composition for down-regulating pro-inflammatory markers | Australia AU2011200854 |
Boswellin® PS |
| 09 | Protective compositions for dermal papilla cells | Australia AU2010326651 |
Saberry® + Cococin™ |
| 10 | Oleanoyl peptide composition and a method of treating skin aging | Australia AU2011265587 |
Olepent® |
| 11 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Australia AU2014369819 |
LactoSporin® |
| 12 | Method for the treatment of hypercholesterolemia | Australia AU2014202312 |
Calebin |
| 13 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Australia AU2012203148 |
Saberry® + Cococin™+ Se Peptide |
| 14 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Australia AU2015308650 |
LactoSpore® |
| 15 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2013292593 |
Cyperus |
| 16 | Composition and method for the protection of articular cartilage | Australia AU2014201769 |
Calebin |
| 17 | Anti-obesity potential of Calebin A | Australia AU2014203122 |
Calebin |
| 18 | Process and compositions for achieving mammalian energy balance | Australia AU2015351423 |
Forskolin |
| 19 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl) butadiene | Australia AU2016385393 |
Zingiber cassumnar |
| 20 | Synthesis of Calebin A and its biologically active analogs | Australia AU2014203764 |
Calebin |
| 21 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Australia AU2017228561 |
LactoSporin® |
| 22 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Canada CA2899511 |
LactoSporin® |
| 23 | Method for the treatment of hypercholesterolemia | Canada CA2963383 |
Calebin |
| 24 | Use of Piperine as a Bioavailability Enhancer | Canada CA2247467 |
BioPerine® |
| 25 | Forskolin for promoting lean body mass | Canada CA2281562 |
ForsLean® |
| 26 | Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins | Canada CA2537820 |
Ocufors® |
| 27 | Anti-obesity Potential of Calebin A | Canada CA2857543 |
Calebinoids |
| 28 | Composition for down-regulating pro-inflammatory markers | Canada CA2732915 |
Boswellin® PS |
| 29 | Hepatoprotectant activity of garcinol | Canada CA2851663 |
Garcinol |
| 30 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Canada CA2872535 |
Saberry® + Cococin™ + Se Peptide |
| 31 | Method for the treatment of hypertriglyceridemia | Canada CA2850999 |
Calebin |
| 32 | Synthesis of Calebin A and its biologically active analogs | Canada CA2858126 |
Calebin |
| 33 | Calebin A for hepatic steatosis | Canada CA2893321 |
Calebin |
| 34 | Composition and method for the protection of articular cartilage | Canada CA2935898 |
Calebin |
| 35 | Calebin A for osteoporosis | Canada CA2941050 |
Calebin |
| 36 | Method to solubilize curcuminoids in water | Canada CA2976689 |
uC3 CLEAR™® |
| 37 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | China ZL201480010615.0 |
LactoSporin® |
| 38 | Process For Preparing Water Soluble Diterpenes And Their Applications | China CN1882508 |
Ocufors® |
| 39 | Compositions and methods for the management of hyperproliferative dermatological conditions | China CN200480043675.9 |
Boswellin® |
| 40 | Anti-obesity potential of Calebin A | China CN201280012577.3 |
Calebin |
| 41 | Melanogenesis inhibition by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof | DPR Korea 1011504 |
Pterowhite |
| 42 | Process For Preparing Water Soluble Diterpenes And Their Applications | Eurasia EA012836 |
Ocufors® |
| 43 | Protective compositions for dermal papilla cells | Eurasia EA020368 |
Saberry® + Cococin™ |
| 44 | Method for the treatment of hypercholesterolemia | Eurasia EA027148 |
Calebin |
| 45 | Use of a composition for down-regulating/inhibiting PGE2 | Eurasia EA023717 |
Bowellin PS |
| 46 | Scirpusin A and Scirpusin B and Anti-obesity potential thereof | Eurasia EA027614 |
Cyperus |
| 47 | Use of Calebin A to protect mammalian articular cartilage from pathological damage | Eurasia EA027614 |
Calebin |
| 48 | Synthesis of Calebin A and its biologically active analogs | Eurasia EA027726 |
Calebin |
| 49 | Use of piperine as a bioavailability enhancer | Europe EP0810868 |
BioPerine® |
| 50 | Bioprotectant composition, method of use and extraction process of curcuminoids | Europe EP0839037 |
Curcumin C3 Complex® |
| 51 | Coconut water and its method of preparation | Europe EP1341547 |
Cococin |
| 52 | Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells | Europe EP1328263 |
Curcumin C3 Reduct® |
| 53 | Bioavailable composition of natural and synthetic HCA | Europe EP1254209 |
Garcitrin |
| 54 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Europe EP1171144 |
Curcumin C3 Reduct® |
| 55 | Forskolin for promoting lean body mass | Europe EP0977564 |
ForsLean® |
| 56 | Compositions Containing Allium Sativumi> Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Europe EP1968620 |
SelenoForce® |
| 57 | Process for preparing water soluble diterpenes and their applications | Europe EP1718568 |
Ocufors® |
| 58 | Compositions and methods for the management of hyperproliferative dermatological conditions | Europe EP1791423 |
Boswellin® |
| 59 | Hepatoprotectant activity of garcinol | Europe EP2658374 |
Garcinol |
| 60 | Protective compositions for dermal papilla cells | Europe EP2461786 |
Saberry® + Cococin™ |
| 61 | Method for the treatment of hypercholesterolemia | Europe EP2937084 |
Calebin |
| 62 | Calebin A for use in the treatment of inflammation and obesity | Europe EP2663185 |
Calebin |
| 63 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Europe EP2695603 |
Saberry® + Cococin™ + Se Peptide |
| 64 | Composition and method for the protection of articular cartilage | Europe EP2893926 |
Calebin |
| 65 | Calebin A for inducing lipolysis | Europe EP3085370 |
Calebin |
| 66 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Europe EP2989197 |
LactoSporin® |
| 67 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Great Britain GB2380675 |
Cosmoperine® |
| 68 | Process for preparing water soluble diterpenes and their applications | Hong Kong HK1098450 |
Ocufors® |
| 69 | Process For Preparing Water Soluble Diterpenes And Their Applications | Hong Kong HK1098450 |
Ocufors® |
| 70 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Hong Kong HK1193758 |
Saberry® +Cococin™ + Se Peptide |
| 71 | Calebin A for articular cartilage | Hong Kong HK1210028 |
Calebin |
| 72 | Anti-obesity potential of Calebin A | Hong Kong HK1190874 |
Calebin |
| 73 | Method for the treatment of hypercholesterolemia | India IN1210590 |
Calebin |
| 74 | A Process for preparing a synergistic composition for treating hyperproliferative dermatological conditions | India IN238950 |
Boswellin® |
| 75 | A Process for obtaining high purity fatty alcohols | India IN229695 |
Policosanol |
| 76 | A Process for obtaining high purity fatty alcohols | Indonesia IDP000051688 |
Saberry® + Cococin™ + Se Peptide |
| 77 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Indonesia IDP00201506134 |
LactoSporin®, LactoSporin® + Sabilize® |
| 78 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Japan JP6064274 |
Saberry® + Cococin™ + Se Peptide |
| 79 | Use of Piperine as a bioavailability enhancer | Japan JP3953513 |
BioPerine® |
| 80 | Process of obtaining compositions of stable Lutein and Lutein derivatives | Japan JP4227409 |
ZeaLutein® |
| 81 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Japan JP4098985 |
Cosmoperine® |
| 82 | Bio-available compositions of natural and synthetic HCA | Japan JP4205943 |
GarCitrin® |
| 83 | Compositions and methods for the management of hyperproliferative dermatological conditions | Japan JP4820819 |
Boswellin® |
| 84 | Process for preparing water soluble diterpenes and their applications | Japan JP5021305 |
Ocufors® |
| 85 | Hepatoprotectant activity of garcinol | Japan JP5980228 |
Garcinol |
| 86 | Composition and method for the protection of articular cartilage | Japan JP6142446 |
Calebin |
| 87 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Japan JP6126307 |
LactoSporin®, LactoSporin® + SabiLize® + antimicrobial and biofilm inhibition |
| 88 | Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6135761 |
Cyperus |
| 89 | Oleanoyl peptide composition and a method of treating skin aging | Japan JP6176893 |
Olepent® |
| 90 | Method for the treatment of hypercholesterolemia | Japan JP6263707 |
Calebin |
| 91 | Calebin A for hepatic steatosis | Japan JP6336943 |
Calebin |
| 92 | Anti-obesity potential of Calebin A | Japan JP6374716 |
Calebin |
| 93 | Process and compositions for achieving mammalian energy balance | Japan JP6472453 |
Forskolin |
| 94 | Synthesis of Calebin A and its biologically active analogs | Japan JP6490927 |
Calebin |
| 95 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Japan JP6584526 |
Zingiber cassumunar |
| 96 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Malaysia MY-168089-A |
Saberry® + Cococin™ + Se Peptide |
| 97 | Method for the treatment of hypercholesterolemia | Malaysia MY-170067-A |
Calebin |
| 98 | Anti-obesity potential of Calebin A | Mexico MX260326 |
Ocufors® |
| 99 | Composition for down-regulating proinflammatory markers | Mexico MX328842 |
Polybos |
| 100 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Mexico MX355546 |
Saberry® + Cococin™ + Se Peptide |
| 101 | Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives | New Zealand NZ552997 |
Forskolin |
| 102 | Compositions and methods for the management of hyperproliferative dermatological conditions | New Zealand NZ552027 |
Boswellin® |
| 103 | Commercial Process for making Forskolin and its derivatives | New Zealand NZ568652 |
Ocufors® |
| 104 | Process for preparing water soluble diterpenes and their applications | New Zealand NZ545765 |
Ocufors® |
| 105 | Bioavailable composition of natural and synthetic HCA | New Zealand NZ518116 |
GarCitrin® |
| 106 | Use of Tetrahydrocurcuminoids to Regulate Physiological and Pathological Events in the Skin and Mucosa | New Zealand NZ514884 |
Curcumin C3 Reduct® |
| 107 | Compositions containing Allium sativum Linn. (garlic) and a concentrate of organic selenium compounds for nutritional supplementation | New Zealand NZ568233 |
SelenoForce® |
| 108 | Protective compositions for dermal papilla cells | New Zealand NZ598630 |
Saberry® + Cococin™ |
| 109 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | New Zealand NZ600307 |
Saberry® + Cococin™ + Se Peptide |
| 110 | Method for the treatment of hypercholesterolemia | New Zealand NZ624269 |
Calebinoids |
| 111 | Hepatoprotectant activity of garcinol | New Zealand NZ609878 |
Garcinol |
| 112 | Antiobesity potential of Calebin A | New Zealand NZ614076 |
Calebin A |
| 113 | Synthesis of Calebin A and its biologically active analogs | New Zealand NZ627247 |
Calebin |
| 114 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | New Zealand NZ622927 |
Cyperus |
| 115 | Anti-obesity potential of Calebin A | New Zealand NZ715053 |
Calebin |
| 116 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | New Zealand NZ711345 |
LactoSporin®, LactoSporin® + SabiLize®+ antimicrobial and biofilm inhibition |
| 117 | Composition and method for the protection of articular cartilage | New Zealand NZ622909 |
Calebin |
| 118 | Method to solubilize curcuminoids in water | New Zealand NZ734491 |
uC3 CLEAR™ |
| 119 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | New Zealand NZ735027 |
Zingiber cassumunar |
| 120 | Process for preparing water soluble diterpenes and their applications | Philippines PH1-2006-500481 |
Ocufors® |
| 121 | Method for the treatment of hypercholesterolemia | Philippines PH1-2014-000244 |
Calebin |
| 122 | Calebin A for Hepatic Steatosis | Philippines PH1-2015-000188 |
Calebin |
| 123 | Composition and method for the protection of articular cartilage | Philippines PH1-2016-501138 |
Calebin |
| 124 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Philippines PH1-2015-502025 |
LactoSporin®, LactoSporin® + Sabilize® |
| 125 | Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685263 |
Cyperus |
| 126 | Composition and method for the protection of articular cartilage | Republic of Korea KR10-1600212 |
Calebin |
| 127 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1685333 |
Calebin |
| 128 | Synthesis of Calebin A and its biologically active analogs | Republic of Korea KR10-1629561 |
Calebin |
| 129 | Method for the treatment of hypercholesterolemia | Republic of Korea KR10-1647549 |
Calebin |
| 130 | Anti-obesity potential of Calebin A | Republic of Korea KR10-1702702 |
Calebin |
| 131 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1717889 |
Cyperus |
| 132 | Calebin A for hepatic steatosis | Republic of Korea KR10-1763474 |
Calebin |
| 133 | Method of producing partially purified extracellular metabolite products from Bacillus Coagulans and biological applications thereof | Republic of Korea KR10-1770902 |
LactoSporin® |
| 134 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Russia 2606752 |
Saberry® + Cococin™ + Se Peptide |
| 135 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Russia RU 2617965 |
LactoSporin®, LactoSporin® + SabiLize® + antimicrobial and biofilm inhibition |
| 136 | Compositions and methods for the management of hyperproliferative dermatological conditions | Russia RU2366412 |
Boswellin® |
| 137 | Hepatoprotectant activity of Garcinol | Russia RU2585245 |
Garcinol |
| 138 | Anti-obesity potential of Calebin A | Russia RU2543334 |
Calebinoids |
| 139 | Calebin A for hepatic steatosis | Russia RU2643297 |
Calebin |
| 140 | Calebin A for Osteoporosis | Russia RU2653103 |
Calebin |
| 141 | Composition comprising Scirpusin A and Scirpusin B and antiobesity potential thereof | Russia RU2691404 |
Cyperus |
| 142 | Anti-cancer activity of (E)-1-(3',4'-Dimethoxyphenyl)butadiene | Russia RU2694053 |
Zingiber cassumunar |
| 143 | Process for preparing water soluble diterpenes and their applications | Singapore SG121197 |
Ocufors® |
| 144 | Compositions and methods for the management of hyperproliferative dermatological conditions | Singapore SG136165 |
Boswellin® |
| 145 | Calebin A for hepatic steatosis | Singapore SG10201503805X |
Calebin |
| 146 | Composition and methods for the protection of articular cartilage | Singapore SG11201605336Y |
Calebin |
| 147 | Anti-obesity potential of Calebin A | Singapore SG192695 |
Calebin |
| 148 | Method of producing partially purified extracellular metabolite products from bacillus coagulans and biological applications thereof | Singapore SG11201505628P |
LactoSporin®, LactoSporin® + SabiLize® |
| 149 | Compositions and methods for the management of hyperproliferative dermatological conditions | South Africa ZA2007/0694 |
Boswellin® |
| 150 | Process for preparing water soluble diterpenes and their applications | South Africa ZA2006/01898 |
Ocufors® |
| 151 | Anti-obesity Potential of Calebin A | South Africa ZA2013/05918 |
Calebinoids |
| 152 | Method to solubilize curcuminoids in water | South Africa ZA2017/06503 |
uC3 CLEAR™ |
| 153 | Composition for down-regulating pro-inflammatory markers | Taiwan I-434696 |
Calebinoids |
| 154 | Method for the treatment of hypercholesterolemia | Taiwan I-622384 |
Calebin |
| 155 | Process for preparing water soluble diterpenes and their applications | Uzbekistan UZ 4028 |
Forskolin Eye Drops |
| 156 | Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same | Vietnam 12717 |
Ocufors® |